The RCOphth is aware of concern from members and industry regarding the current payment arrangements for Microinvasive Glaucoma Surgery (MIGS). Extensive work has been going on behind scenes, working with the ophthalmology Expert Working Group (EWG), glaucoma specialists and the RCOphth professional standards team.

NHSE/I have published ‘Key areas of work for the 2020 national tariff’ which sets out the key policy areas NHSE/I are considering for 2020 and builds on the engagement webinars and workshops earlier in the year.

The College is offering members the opportunity to propose a seminar topic as part of our annual seminar and events programme.

Allergan has contacted the RCOphth to provide a follow up regarding the hold on XEN 45. Allergan has reached out to regulatory agencies, and is working to initiate a voluntary recall of affected lots of XEN 45.

The RCOphth is delighted to share the news that Jugnoo Rahi, RCOphth Academic Chair and Lola Solebo won awards alongside a high quality line up of nominations at the Vision UK Forward View Eye Health and Sight Loss Conference held in collaboration with the Royal Society of Medicine (RSM) in October 2019.

There are 700,000 people in the UK living with glaucoma, an eye disease that without treatment typically causes loss of vision. Over the next ten years, glaucoma cases are predicted to rise by 22% and over 20 years by 44%.